Cogent Biosciences (COGT) Market Cap 2018–2026

As of October 29, 2026, Cogent Biosciences had a market cap of $5.486 billion, which decreased by 0.83% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Cogent Biosciences logo

Cogent Biosciences, Inc. (COGT)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$5.486B ▼ 0.83%
Start of 2026
$5.453B ▲ 0.61%
1 Year Ago
$2.267B ▲ 142.02%
All-Time High
$7.318B ▼ 25.03%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Cogent Biosciences Market Cap History by Year and Month

Cogent Biosciences Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$5.486B▲ 0.61%
$5.486B▼ 0.18%
$5.496B▼ 8.51%
$6.007B▼ 9.67%
$6.65B▲ 0.59%
$6.611B▲ 10.66%
$5.974B▼ 2.27%
$6.113B▼ 2.15%
$6.247B▼ 0.94%
$6.306B▲ 14.40%
$5.512B▲ 1.08%
2025$5.453B▲ 532.60%
2024$0.862B▲ 70.36%
2023$0.506B▼ 37.38%
2022$0.808B▲ 114.89%
All market cap values reflect closing prices for the period shown.

📊 Cogent Biosciences Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:

  1. $12.85B
  2. $11.13B
  3. $10.21B
  4. $10.15B
  5. $9.97B
  6. $9.61B
  7. $9.34B
  8. $9.07B
  9. $8.79B
  10. $8.54B
  11. $8.06B
  12. $7.35B
  13. $7.1B
  14. $6.41B
  15. $5.49B
  16. $5.37B
  17. $5.25B
  18. $3.43B
  19. $2.03B
  20. $1.65B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.